Your browser doesn't support javascript.
loading
Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008.
Schlichting, Jennifer A; Soliman, Amr S; Schairer, Catherine; Harford, Joe B; Hablas, Ahmed; Ramadan, Mohamed; Seifeldin, Ibrahim; Merajver, Sofia D.
Afiliação
  • Schlichting JA; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA.
  • Soliman AS; Department of Epidemiology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Schairer C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
  • Harford JB; Center for Global Health, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA.
  • Hablas A; Tanta Cancer Center, Tanta, Gharbiah 31111, Egypt.
  • Ramadan M; Tanta Cancer Center, Tanta, Gharbiah 31111, Egypt.
  • Seifeldin I; Tanta Cancer Center, Tanta, Gharbiah 31111, Egypt.
  • Merajver SD; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA ; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Biomed Res Int ; 2015: 381574, 2015.
Article em En | MEDLINE | ID: mdl-26495294
ABSTRACT

OBJECTIVE:

Although breast cancers (BCs) in young women often display more aggressive features, younger women are generally not screened for early detection. It is important to understand the characteristics of young onset breast cancer to increase awareness in this population. This analysis includes all ages, with emphasis placed on younger onset BC in Egypt as compared to the United States.

METHODS:

BC cases in the Gharbiah cancer registry (GCR), Egypt, were compared to those in the Surveillance, Epidemiology, and End Results (SEER) database. This analysis included 3,819 cases from the GCR and 273,019 from SEER diagnosed 2004-2008.

RESULTS:

GCR cases were diagnosed at later stages, with <5% diagnosed at Stage I and 12% diagnosed at Stage IV. 48% of all SEER cases were diagnosed at Stage I, dropping to 30% among those ≤40. Significant differences in age, tumor grade, hormone receptor status, histology, and stage exist between GCR and SEER BCs. After adjustment, GCR cases were nearly 45 times more likely to be diagnosed at stage III and 16 times more likely to be diagnosed at stage IV than SEER cases.

CONCLUSIONS:

Future research should examine ways to increase literacy about early detection and prompt therapy in young cases.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sistema de Registros / Vigilância da População / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Sistema de Registros / Vigilância da População / Detecção Precoce de Câncer Idioma: En Ano de publicação: 2015 Tipo de documento: Article